• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正常和病理体液中活性可溶性人CD38形式的鉴定与表征

Identification and characterization of an active soluble form of human CD38 in normal and pathological fluids.

作者信息

Funaro A, Horenstein A L, Calosso L, Morra M, Tarocco R P, Franco L, De Flora A, Malavasi F

机构信息

Department of Genetics, Biology and Medical Chemistry, University of Turin, Italy.

出版信息

Int Immunol. 1996 Nov;8(11):1643-50. doi: 10.1093/intimm/8.11.1643.

DOI:10.1093/intimm/8.11.1643
PMID:8943558
Abstract

Human CD38 is a transmembrane glycoprotein involved in lymphocyte activation and adhesion to endothelium. The ectocellular domain of the molecule possesses properties of a bifunctional enzyme catalyzing both the synthesis from NAD+ and the hydrolysis of the calcium-releasing metabolite cyclic ADP-ribose (cADPR). Surface expression of CD38 (mCD38) is rapidly and almost completely down-modulated upon ligation by specific mAb in cells from different lineages. The data presented here also show that, in addition to the existence of a mCD38, a soluble form of CD38 (sCD38) is detectable in the cell culture supernatant of allo-activated T lymphocytes and of several tumor cell lines. sCD38 is also present in vivo and is assayable in normal (fetal serum and amniotic fluid) and pathological (serum and ascites from patients with multiple myeloma, and serum from patients with AIDS) biological fluids. Immunoaffinity chromatography, SDS-PAGE and Western blot analyses with mAb and polyclonal antibodies, along with metabolic labeling, yield a body of data concerning the structure of sCD38, which displays a M(r) of 39 kDa. Native sCD38 maintains the ability to inhibit the binding activity of different anti-CD38 mAb and still catalyzes the synthesis and the hydrolysis of cADPR at the same ratio observed with mCD38. Furthermore, cross-linking experiments indicate that the purified soluble molecule binds a 120 kDa molecule expressed by monocytoid cells and identified as a candidate ligand for human mCD38.

摘要

人类CD38是一种跨膜糖蛋白,参与淋巴细胞活化以及与内皮细胞的黏附。该分子的胞外结构域具有双功能酶的特性,既能催化由NAD⁺合成,又能催化钙释放代谢物环ADP核糖(cADPR)的水解。在不同谱系的细胞中,特异性单克隆抗体(mAb)结合后,CD38(mCD38)的表面表达会迅速且几乎完全下调。本文提供的数据还表明,除了存在mCD38外,在同种异体激活的T淋巴细胞和几种肿瘤细胞系的细胞培养上清液中可检测到可溶性形式的CD38(sCD38)。sCD38在体内也存在,并且可在正常(胎儿血清和羊水)和病理(多发性骨髓瘤患者的血清和腹水,以及艾滋病患者的血清)生物体液中检测到。使用mAb和多克隆抗体进行免疫亲和色谱、SDS-PAGE和蛋白质印迹分析,以及代谢标记,产生了一系列关于sCD38结构的数据,其分子量(M(r))为39 kDa。天然sCD38保持抑制不同抗CD38 mAb结合活性的能力,并且仍以与mCD38相同的比例催化cADPR的合成和水解。此外,交联实验表明,纯化的可溶性分子与单核细胞样细胞表达的120 kDa分子结合,该分子被鉴定为人类mCD38的候选配体。

相似文献

1
Identification and characterization of an active soluble form of human CD38 in normal and pathological fluids.正常和病理体液中活性可溶性人CD38形式的鉴定与表征
Int Immunol. 1996 Nov;8(11):1643-50. doi: 10.1093/intimm/8.11.1643.
2
NAD+-dependent internalization of the transmembrane glycoprotein CD38 in human Namalwa B cells.人Namalwa B细胞中跨膜糖蛋白CD38的NAD+依赖性内化作用
FEBS Lett. 1996 Nov 4;396(2-3):327-32. doi: 10.1016/0014-5793(96)01125-8.
3
Formation and hydrolysis of cyclic ADP-ribose catalyzed by lymphocyte antigen CD38.淋巴细胞抗原CD38催化的环ADP核糖的形成与水解
Science. 1993 Nov 12;262(5136):1056-9. doi: 10.1126/science.8235624.
4
CD38 and ADP-ribosyl cyclase catalyze the synthesis of a dimeric ADP-ribose that potentiates the calcium-mobilizing activity of cyclic ADP-ribose.CD38和ADP-核糖基环化酶催化二聚体ADP-核糖的合成,该二聚体可增强环ADP-核糖的钙动员活性。
J Biol Chem. 1997 May 16;272(20):12945-51. doi: 10.1074/jbc.272.20.12945.
5
Self-aggregation of purified and membrane-bound erythrocyte CD38 induces extensive decrease of its ADP-ribosyl cyclase activity.纯化的和膜结合的红细胞CD38的自我聚集会导致其ADP核糖基环化酶活性大幅下降。
FEBS Lett. 1995 Feb 6;359(1):35-40. doi: 10.1016/0014-5793(95)00005-t.
6
Expression of cell surface markers during differentiation of CD34+, CD38-/lo fetal and adult bone marrow cells.CD34+、CD38-/lo 胎儿及成人骨髓细胞分化过程中细胞表面标志物的表达
Immunomethods. 1994 Dec;5(3):179-88. doi: 10.1006/immu.1994.1054.
7
Human CD38 ligand. A 120-KDA protein predominantly expressed on endothelial cells.人CD38配体。一种主要在内皮细胞上表达的120千道尔顿蛋白质。
J Immunol. 1996 Jan 15;156(2):727-34.
8
Secretion of IFN-gamma, IL-6, granulocyte-macrophage colony-stimulating factor and IL-10 cytokines after activation of human purified T lymphocytes upon CD38 ligation.人纯化T淋巴细胞经CD38连接激活后,IFN-γ、IL-6、粒细胞-巨噬细胞集落刺激因子和IL-10细胞因子的分泌情况。
Cell Immunol. 1996 Nov 1;173(2):192-7. doi: 10.1006/cimm.1996.0267.
9
Estrogen increases CD38 gene expression and leads to differential regulation of adenosine diphosphate (ADP)-ribosyl cyclase and cyclic ADP-ribose hydrolase activities in rat myometrium.雌激素可增加CD38基因的表达,并导致大鼠子宫肌层中二磷酸腺苷(ADP)-核糖基环化酶和环ADP-核糖水解酶活性的差异调节。
Biol Reprod. 2002 Mar;66(3):596-602. doi: 10.1095/biolreprod66.3.596.
10
Enzymatic synthesis and characterizations of cyclic GDP-ribose. A procedure for distinguishing enzymes with ADP-ribosyl cyclase activity.环鸟苷二磷酸核糖的酶促合成与表征。一种区分具有ADP - 核糖基环化酶活性的酶的方法。
J Biol Chem. 1994 Dec 2;269(48):30260-7.

引用本文的文献

1
Monoclonal anti-CD38 therapy in human myeloma: retrospects and prospects.人骨髓瘤中的单克隆抗CD38疗法:回顾与展望。
Front Immunol. 2025 Feb 12;16:1519300. doi: 10.3389/fimmu.2025.1519300. eCollection 2025.
2
Functional identification of soluble uric acid as an endogenous inhibitor of CD38.鉴定可溶性尿酸作为 CD38 的内源性抑制剂的功能。
Elife. 2024 Nov 11;13:RP96962. doi: 10.7554/eLife.96962.
3
Combining CD38 antibody with CD47 blockade is a promising strategy for treating hematologic malignancies expressing CD38.联合 CD38 抗体和 CD47 阻断是治疗表达 CD38 的血液系统恶性肿瘤的一种有前途的策略。
Front Immunol. 2024 Jun 25;15:1398508. doi: 10.3389/fimmu.2024.1398508. eCollection 2024.
4
Quantitative systems pharmacology modeling sheds light into the dose response relationship of a trispecific T cell engager in multiple myeloma.定量系统药理学模型揭示了三特异性 T 细胞接合器在多发性骨髓瘤中的剂量反应关系。
Sci Rep. 2022 Jun 29;12(1):10976. doi: 10.1038/s41598-022-14726-5.
5
COVID-19: Are We Facing Secondary Pellagra Which Cannot Simply Be Cured by Vitamin B3?新型冠状病毒肺炎:我们是否面临不能仅用维生素 B3 治愈的继发性糙皮病?
Int J Mol Sci. 2022 Apr 13;23(8):4309. doi: 10.3390/ijms23084309.
6
Anti CD38 monoclonal antibodies for multiple myeloma treatment.抗 CD38 单克隆抗体治疗多发性骨髓瘤。
Hum Vaccin Immunother. 2022 Nov 30;18(5):2052658. doi: 10.1080/21645515.2022.2052658. Epub 2022 Apr 11.
7
CD38 in the age of COVID-19: a medical perspective.新冠疫情时代的CD38:医学视角
Physiol Rev. 2021 Oct 1;101(4):1457-1486. doi: 10.1152/physrev.00046.2020. Epub 2021 Mar 31.
8
Enzymology of extracellular NAD metabolism.细胞外烟酰胺腺嘌呤二核苷酸代谢的酶学
Cell Mol Life Sci. 2021 Apr;78(7):3317-3331. doi: 10.1007/s00018-020-03742-1. Epub 2021 Mar 23.
9
CD38 ecto-enzyme in immune cells is induced during aging and regulates NAD and NMN levels.免疫细胞中的 CD38 外切酶在衰老过程中被诱导,并调节 NAD 和 NMN 水平。
Nat Metab. 2020 Nov;2(11):1284-1304. doi: 10.1038/s42255-020-00298-z. Epub 2020 Nov 16.
10
The Circular Life of Human CD38: From Basic Science to Clinics and Back.人类 CD38 的循环生命:从基础科学到临床再到基础科学。
Molecules. 2020 Oct 21;25(20):4844. doi: 10.3390/molecules25204844.